In 2021, the global gene therapy market was estimated to be worth $1.55 billion USD. The market is expected to increase from US$ 1.85 billion in 2022 to US$ 10.1 billion by 2032, at an 18.5%… Read More
Ionis Pharmaceuticals (IONS) is a renowned biotech company specializing in RNA-targeted therapeutics. Despite generating a significant revenue of $587.37 million, the company experienced a l… Read More
[Sept. 24, 2023: Staff Writer, The Brighter Side of News]
Enzyme GCN5 is key in skeletal muscle loss due to aging. (CREDIT: Creative Commons)
A recent study published in the Journal of C… Read More
The gene therapy market size is poised to grow by $ 15.68 billion by 2030 from $ 3.59 Billion in 2022, exhibiting a CAGR of 20.2% during the forecast period 2022 to 2030.
Key Ta… Read More
SHANGHAI, May 3, 2023 /PRNewswire/ — Skyline Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rar… Read More
Top Biotech Companies in the USA: Revolutionizing the Future of Healthcare
Discover the top biotech companies in the USA that are spearheading innovation and transforming the healthcare indu… Read More
“Orphan” drug status is offering these ASX pharma stocks a chance to turn a healthy profit – and give hope to those suffering rare conditions.
Rare or “orphan&rd… Read More
Introduction
Transcription is the process by which genetic information in DNA is copied into RNA molecules. This process is carried out by an enzyme called RNA polymerase, which moves along… Read More
VYGR (NASDAQ: VYGR) Forecasts for Voyager Therapeutics, Inc.’s earnings per share (EPS) were presented to clients and investors by Wedbush analysts on January 9th. This year, the compa… Read More
Are you looking to improve your fitness game by consuming the best supplement? You may have heard of Branch Chain Amino Acids (BCAAs) and Essential Amino Acids (EAAs), but have yet to determ… Read More
The ‘Global Adeno-Associated Virus Vector-Based Gene Therapy Market Size, Share, Price, Trends, Growth, Report and Forecast 2023-2031’ by Expert Market Research gives an ext… Read More
The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic.
Give… Read More
Delveinsight Business Research LLP
The Centronuclear Myopathy (CNM) therapeutics market is set to evolve significantly in the coming years owing to the rise in the number of incident ca… Read More
1 Introduction Skeletal muscle money owed for 40–50% of lean physique mass, making it probably the most largest organs in the physique and the largest protein respository (Sartori et… Read More
According to this report, Intracranial Therapeutic Delivery Market study is an intelligence report with meticulous efforts to study accurate and valuable information. The data reviewed… Read More
The 4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference on the 20th & 21st of October 2022 aims to delve deep into defining trends & innovation withing the bioprocessing e… Read More
Key Factors Driving Market Growth:The major factors driving the
growth of oligonucleotide synthesis market include the increasing use of
synthesized oligos in therapeutic applications, incre… Read More
Mitsubishi Tanabe Pharma America last week announced US Food and Drug Administration (FDA) approval of RADICAVA ORS® (edaravone), a medication for patients with amyotrophic lateral scler… Read More
Buy Now
Neurodegenerative disorder therapeutics market comprises of sales of neurodegenerative disease therapeutics products & related services for the neurodegenerative disorders. Neuro… Read More
This report aims to provide detailed insights
into the Oligonucleotide Synthesis Market. It
provides valuable information on the type, procedure, application, and region
in the market. Furth… Read More
The US Food and Drug Administration (FDA) has placed a clinical hold on BioMarin Pharmaceutical’s investigational gene therapy BMN 307 for the rare inherited disease phenylketonuria (P… Read More
More than $18,000 was raised at the 11th Walk for Muscular Dystrophy at McKenzie Trails in Red Deer Saturday afternoon. Dhatt-O’Leary was the ambassador for the Red Deer Walk for Mus… Read More
We are living in a world where we have several technological advances in a short period of time. Science is allowing us to know more about the world we live in and how to make the most out o… Read More
The study involved four major activities to estimate the current size of the global active pharmaceutical ingredient market. Exhaustive secondary research was done to collect information on… Read More
In rare disease trials, it’s not always feasible to choose clinically-relevant endpoints to measure the efficacy of a new therapeutic. Often, the potential patient pool for a given tri… Read More
Last year, drug producer Brainstorm Cell Therapeutics received significant criticism for attempting to offer patients access to an experimental treatment procedure for amyotrophic lateral sc… Read More